Wade Blair
Intego (Germany)(DE)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, Cytokine Signaling Pathways and Interactions, Hepatitis C virus research, Respiratory viral infections research
Most-Cited Works
- → A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding(2003)360 cited
- → HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention(2010)298 cited
- → Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis(2014)289 cited
- → Discovery of 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): A Novel HIV-1 Attachment Inhibitor That Interferes with CD4-gp120 Interactions(2003)206 cited
- → BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents(2000)195 cited
- → A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors(2013)125 cited
- → Lead identification of novel and selective TYK2 inhibitors(2013)122 cited
- → Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module.(1994)104 cited
- → Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors(2013)97 cited
- → Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations(2016)93 cited